Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A group of “immunological nonresponders” wants the FDA to grant them orphan disease status.
Researchers will genetically engineer participants’ CD4 cells, disabling the attachment of the virus.
Two of three in one cohort of Sangamo Biosciences’ investigational gene therapy have maintained control of the virus for an extended period.
Cutting through the hype and hyperbole.
Futuristic highlights from the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston.
The drug Cytoxan is safe and relatively well tolerated and augments the uptake of immune cells genetically engineered to resist HIV.
A technique for genetically modifying the immune cells of people with HIV to resist the virus has shown promise in an early trial.
A study of a genetic therapy has reduced the size of the HIV reservoir in seven of nine study subjects and has also led to long-term CD4 incre...
October 5 is an occasion to learn about and advocate for HIV cure research.
Scientists have proved that it is possible to engineer immune cells to control HIV for a sustained period of time without the need for ongoing...
Scientists at Stanford University School of Medicine have created an advanced method of engineering CD4 cells to resist HIV infection.
Crowds flooded the “pathways toward a cure” session at the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle...
Participating in clinical trials can bolster your health—and that of the whole community.
Right now there are few promising treatments under study to boost CD4s in immunologic non-responders.
After an HIV-positive man known as the ’Trenton patient’ underwent an experimental gene therapy procedure, his body was able to briefly contro...
Sounds wacky, doesn’t it?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.